Evidence map›Paper›PMID 40074243›Full record

ArticleJournal of cerebrovascular and endovascular neurosurgery2025

Multi-modal management of aggressive vertebral hemangioma: A single center experience.

Mohamed Farouk, Mohamed Ali Kassem, Ashraf Ezzeldein, Mohamed Mohsen Ameen, Ali Hassan Elmokadem, Mohamed M Elsherbini

Abstract read
In one paragraph

Article in Journal of cerebrovascular and endovascular neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohamed FaroukDepartment of Neurosurgery, Mansoura University, Mansoura, Egypt.
Mohamed Ali KassemDepartment of Neurosurgery, Mansoura University, Mansoura, Egypt.
Ashraf EzzeldeinDepartment of Neurosurgery, Mansoura University, Mansoura, Egypt.
Mohamed Mohsen AmeenDepartment of Neurosurgery, Mansoura University, Mansoura, Egypt.
Ali Hassan ElmokademDepartment of Neurosurgery, Mansoura University, Mansoura, Egypt.
Mohamed M ElsherbiniDepartment of Neurosurgery, Mansoura University, Mansoura, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aims at spotlighting different lines of management of aggressive vertebral hemangioma (VH) through a retrospective analysis of single center experience.

methodsPatients diagnosed with aggressive VHs in a tertiary referral center were reviewed from 2014 through 2024. Data of patients who met the inclusion criteria were analyzed. Patients of all ages, both sexes, and all varieties of clinical presentation were included, only patients who underwent at least one intervention were included.

resultsThe study included nine patients, comprising six females and three males, with a mean age of 29.3 years (ranging from 14 to 46). Six patients underwent Trans-arterial embolization (TAE), of whom five underwent further surgical procedures, while one patient found TAE to be sufficient as a stand-alone management technique. Eight patients underwent surgical management, five of whom were pre-operatively embolized.

conclusionsAggressive VHs are rare, and their management is challenging. Most cases require a multi-modal management, especially when presented with neurological deficit. Pre-operative embolization and/or vertebroplasty are safe and useful tools to decrease intra-operative bleeding of such a vascular pathology in cases undergoing open surgical procedures.

Indexed as

LaminectomySclerotherapyTherapeutic embolizationVertebral hemangiomaVertebroplasty

Identifiers

PMID40074243
PMCPMC11984272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.